Advertisement Pharmaceutical Business review - Page 182 of 5283 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 24, 2026

BeOne to invest $300m in US manufacturing facility expansion

BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.

Continue
The development involves the construction of a three-storey building adjacent to BeOne’s existing Hopewell site. Credit: BeOne Medicines / Business Wire.
July 24, 2026

FDA grants fast track designation for Lundbeck’s Lu AH69593

Narcolepsy is described as a chronic neurological condition that affects the brain’s regulation of sleep and wakefulness. Credit: Toa55 / Shutterstock.com.
July 23, 2026

Evogene and ELEO to develop new oral PCSK9 inhibitors

The companies intend to identify and advance differentiated oral small molecules that could offer alternatives in the expanding market. Credit: Wasan Tita/Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Affinia Therapeutics receives FDA orphan drug designation for AFTX-201
  2. Kyowa Kirin EMEA’s Crysvita approved by EC for infants with XLH
  3. Cellares and Papillon partner for PPL-001 manufacturing automation
  4. EMA’s CHMP grants PRIME status to AbelZeta’s C-CAR168
  5. Halozyme and Incyte sign licence agreement for INCA033989 formulations

PRESS RELEASES

SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
Dr Imre Molnár Met Professor Ugur Sahin in Berlin, Laureate of the German National Prize, Together With His Wife Professor Özlem Türeci
Dr Imre Molnár Met Professor Ugur Sahin in Berlin, Laureate of the German National Prize, Together With His Wife Professor Özlem Türeci

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography